chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt c/o SOB, throat swelling which progressed to difficulty swallowing. Epi IM given x1 then transferred to ED
I have had severe joint pain, lasted two weeks at that level and then seemed to be getting better. This is why I didn?t bother reporting it, and I was still mobile during the pain. Then the bone/joint pain started to increase again. I called my doctor to inform her of what was going on and that I am now unable to walk, stand, sit due to the severity of the pain.  Weak muscles. When I received the second dose I got slightly dizzy and felt a hot flash type symptom, it was very brief. I waited the required time before leaving the facility.
Site: Pain at Injection Site-Mild, Systemic: Abdominal Pain-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: patients pulse and heart rate decreased -Severe, Systemic: Hypotension-Severe
Arm pain/soreness post 1 week injection after getting PNEUMOVAX in right arm.
Itchy face and hands progressed to itchy inside ears Tingling lips and, face and hands Swallowing seemed like saliva was thick so I couldn?t fully swallow. Itchy throat (internal) Breathing NOT affected
Headache, Arthralgia,  FATIGUE, TENDER/SWELLING INJ SITE  Narrative:
PERICARDITIS; MILD HEART PALPITATIONS (TINGES); VIRAL INFECTION; This spontaneous report received from a patient via a company representative via social media (J and J Corporate account) concerned a 59 year old of unspecified sex, race and ethnicity.   The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was in perfect health and had never been in an ER (emergency room) before vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. Age at time of vaccination 6 decade old. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced mild heart palpitations (tinges) every 20 minutes or so after the vaccine and within 2 months of getting the vaccine patient experienced pericarditis after a viral infection. It was reported as "I had had mild heart palpitations (tinges) every 20 minutes or so after I got the J and J. They subsided after 2 days and I then got Periocarditis after a virus within 2 months or getting the vaccine. I wound up in the emergency room (I was 59, in perfect health and had never been in an ER) thinking I was having a heart attack. I am totally convinced that the J&J caused these issues" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from mild heart palpitations (tinges), and the outcome of pericarditis and viral infection was not reported. This report was serious (Other Medically Important Condition). This case is a duplicate of 20221153030.; Sender's Comments: V0:20221151295-Pericarditis. The event has a compatible/suggestive temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event. Therefore, this event is considered consistent with vaccine administration.
Patient received the second dose beyond the 25-35 days of time interval after first dose; a little soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a little soreness in the arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received the second dose beyond the 25-35 days of time interval after first dose) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 015M20A) for COVID-19 vaccination.     There was no history of COVID-19 infection reported. There was no history of Myocarditis/pericarditis reported. Patient was not tested or diagnose for Covid-19 as patient was tested periodically and did not had any symptoms.  Concurrent medical conditions included Allergy to antibiotic (Allergy to Tetracycline).   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received the second dose beyond the 25-35 days of time interval after first dose). In March 2021, the patient experienced PAIN IN EXTREMITY (a little soreness in the arm). At the time of the report, PAIN IN EXTREMITY (a little soreness in the arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received the second dose beyond the 25-35 days of time interval after first dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information were reported.   This case was linked to MOD-2022-571226, MOD-2022-571142, MOD-2022-571165 (Patient Link).
Soar arm; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 at 18:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure abnormal. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination included medication (unspecified) for blood pressure from an unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 07:00, the patient experienced soar arm. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event soar arm was resolved on 11Mar2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pain; This case was reported by a consumer via call center representative and described the occurrence of pain in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th August 2019, the patient received the 1st dose of Shingrix. On 16th August 2019, immediately after receiving Shingrix, the patient experienced pain. Shingrix was continued with no change. On 19th August 2019, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional case details were reported as follows: The reporter was patient's wife. The patient received vaccine in right arm. The patient developed pain shortly after receiving the vaccine.  The pain resolved after 3 days. The contact information was not available at the time of the call. The reporter did not provide any additional details. The reporter consented to follow up. This case had been linked to the case US2019166402, reported by same reporter.
04/19/2002 SKB 546A@ expires 10/03, 0.5 sec IM RA, 04.22.02 Child's mother phoned indicating injection site is red, swollen, tender to touch. Instructed to apply ice to site and administer Benadryl for swelling.
sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a elderly female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: Age at vaccination was not reported. After a flu shot, the patient's arm was very sore. The patient consented to follow up. The patient stated, she experienced same event when she got a Shingrix dose (refer case US2019060185).
Patient reports sore left arm after receiving 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Patient reports sore left arm after receiving 1st dose) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M2019) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN IN EXTREMITY (Patient reports sore left arm after receiving 1st dose). At the time of the report, PAIN IN EXTREMITY (Patient reports sore left arm after receiving 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided   Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: NNI
Left arm pain, sweating, low grade fever, chest tightness, joint pain, itching/burning skin, and hives.
Male patient, after the first dose of the pfizer vaccine reports feeling dizzy, dry mouth, tremors and cramping. Patient is anxious.  Vital signs B/P 120/90, P63, Dextro 85, SPO2 99% are taken. Dr. is consulted which indicates that it is left in observation for 30 min and "gatorade" is provided.  At 30 min vital B/P 120/62, SPO2 100%, P 73, PATIENT REPORTS FEELING BETTER AND NOT HAVING CRAMPS OR TREMORS. Patient proceeds to withdraw from the vaccination center under his own.
This case was reported by a nurse via call center representative and described the occurrence of pain in arm in a female patient who received SHINGRIX for prophylaxis. In November 2017, the patient received SHINGRIX. On an unknown date, less than a week after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The caller reported that she received the vaccine and the first week was sore and achy pain in her arm where she received the shot. Then the pain was getting worse and could not even put her clothes on. The caller stated that, she went to the physician in January and May but at the reporting time, she was still in pain. The caller had already reported the adverse events (AE), but the safety department was unable to locate the AE on their end. This call had been transferred to Medical information for further assistance.
her elbow started hurting\ joint pain; extreme joint pain; her ankles started hurting; her wrists started hurting; other joint pain during the third week and they are lingering; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (her elbow started hurting\ joint pain), ARTHRALGIA (extreme joint pain), ARTHRALGIA (her ankles started hurting), ARTHRALGIA (her wrists started hurting) and ARTHRALGIA (other joint pain during the third week and they are lingering) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (her elbow started hurting\ joint pain), ARTHRALGIA (extreme joint pain), ARTHRALGIA (her ankles started hurting), ARTHRALGIA (her wrists started hurting) and ARTHRALGIA (other joint pain during the third week and they are lingering). At the time of the report, ARTHRALGIA (her elbow started hurting\ joint pain), ARTHRALGIA (extreme joint pain), ARTHRALGIA (her ankles started hurting), ARTHRALGIA (her wrists started hurting) and ARTHRALGIA (other joint pain during the third week and they are lingering) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications reported. no treatment details reported.
11/13/2001 in the PM, the patient had discomfort in her right arm and hand and felt numb by midnight. The patient awakened in extreme pain and called her MD. The pain is constant down the patient's right arm and she is unable to bend her elbow. The patient was treated with Vicodin and an anti-inflammatory. The patient has pain in the right axillary region, near the anterior scapula.
Patient received her vaccination and stated that she was feeling lightheaded. Patient was cool and clammy, sweating and stated she didnt feel good. EMS notified and hooked up to monitors. IV line was started and patient was transported to the hospital. Patients mother and sister were on site.
pt recvd vax 9FEB92 between 3-4PM; APAP given around 5; began crying 6-cont til 730 or 8; fever devel to 102-103; 102.8 @ one point p/APAP given;
Symptoms began with 12 hours of injects. These include excruciating pain in muscles and joints, muscle cramping, headache, chills, and a temperature of 100 degrees. At its worse, I would say that it was far worse than any flu I have had in the past, and was worse than the second shingle shot that I received several months ago. The symptoms last for around 12 hours.
Swollen; RASH; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen) and RASH (RASH) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form(s). On 09-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swollen) and RASH (RASH). At the time of the report, VACCINATION SITE SWELLING (Swollen) and RASH (RASH) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 09-Feb-2021: No specific follow-up information recorded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.            No concomitant medications were reported  No treatment information was provided   This case was linked to MOD-2021-303220 (Patient Link).
NOT FEELING TOO AWARE; DIZZY; TINGLING AT INJECTION SITE; WEAKNESS ALL OVER BODY; This spontaneous report received from a patient concerned a 27 year old male. The patient's height, and weight were not reported. The patient's past medical history included traumatic brain injury. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: 21-JUN-2021) dose was not reported, administered on 29-MAR-2021 13:00 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the subject experienced not feeling too aware. On 29-MAR-2021, the subject experienced dizzy. On 29-MAR-2021, the subject experienced tingling at injection site. On 29-MAR-2021, the subject experienced weakness all over body. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tingling at injection site, and weakness all over body on 2021, and had not recovered from not feeling too aware, and dizzy. This report was non-serious.
The patient received vaccine after being more than 30 days stored in the fridge; No adverse event; The patient received vaccine after being more than 30 days stored in the fridge; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received vaccine after being more than 30 days stored in the fridge), PRODUCT STORAGE ERROR (The patient received vaccine after being more than 30 days stored in the fridge) and NO ADVERSE EVENT (No adverse event) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005c21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received vaccine after being more than 30 days stored in the fridge). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The patient received vaccine after being more than 30 days stored in the fridge) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received vaccine after being more than 30 days stored in the fridge), PRODUCT STORAGE ERROR (The patient received vaccine after being more than 30 days stored in the fridge) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (The patient received vaccine after being more than 30 days stored in the fridge) and PRODUCT STORAGE ERROR (The patient received vaccine after being more than 30 days stored in the fridge).    It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Concomitant medication of the patient was not reported.  It was reported that the vaccine dose would be either 1st or 2nd. Vaccines were stored in the fridge on 30-Jun-2021 and best used date was reported as 30-Jul-2021.  The patient did not report any side effects.  No treatment information was provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-698994 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-698994:Master case
During the evening (after going to bed) started having chills and body felt "heavy". When awoke the next morning felt fine but noticed slight loss of energy and laying down (not necessarily sleeping) felt better than sitting up.
Pt. states 3 weeks after injection she experienced extreme pain in her shoulder, arm, neck and upper back. She saw her PCP who felt it was due to vaccine. She was placed on Prednisone x 5 days and then an 11 day taper after the 5 days which didn't help. Has seen chiropractor and acupunction. No relief.
a healthy teenage girl who died six months after a third HPV vaccine.; This spontaneous report was received from a physician via social media referring to a teenage female patient of unknown age. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided).  On an unknown date, the healthy teenage patient died six months after a third HPV vaccine. It was unknown whether an autopsy was performed.  The causal relationship between her death and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was not provided.; Sender's Comments:  US-009507513-2303USA005728:MSD
Pt received her second flu shot on 11/26/03 at 2:45.  Her first shot was received one month earlier (this was her first year with the flu shot).  After her first shot she seemed to have a wheeze, but we all assumed it was a cold.  After the second flu shot, she woke up at 3:00 on 11/27/03 with a strange sounding cough.  She coughed all day and seemed tired.  Again we assumed she was coming down with a cold.  At 7:30 pm I noticed she was breathing funny.  At 10:00 pm we noticed her breathing was even worse and labored.  We immediately called the on call physician from Medical Office and then rushed her to Hospital. Doctors in the ER advised she was in respatory distress.  She was placed on a nebulizer for 3 treatments, given steroids orally, and received a chest x-ray to rule out pneumonia.  After being stabilized she was discharged from the hopsital at 2:30 am on 11/28/03.  It is suspected that Arianna may be allergic to something on the list that would indicate she should not get flu shots.  She will be tested for allergies shortly to help us determine what it is she may be allergic to.  We know it is not eggs.  Pt will be on oral seroids for the next 3-5 days and now has an inhaler.
Presented to emergency department on 3/21/2021 with shortness of breath, coughing, fatigue, chills, and loss of appetite. Was found to be COVID-19 positive. He was admitted for further management to regional Medical facility.
I had like a allergy in my throat that is how it felt. I started to get a stuffy nose and my eyes was getting watery and I started to get the chills. I had a fever 99.7. I started to get nausea for 2 days. When I woke up, I took a COVID test, and it was positive. I was really tired.
Severe joint pain in lower body, fever 101.4 lasting 48 hours; visibly swollen and painful lymph node above collar bone on right side; no appetite for 24 hours; slight cough, abdominal pain/cramping beginning after 48 hours; headache; malaise; sore arm at injection site.  Unable to go to work for three days (and counting).
Admit 1/24/23 with right hip fracture after a mechanical fall, s/p right hemiarthroplasty 1/25.  Now discharged and readmitted twice with agitated dementia. Currently admitted.  He previously lived at home with his spouse and will no longer be able to return home.  He needs permanent memory care placement.
8JUN 1030AM restless, crying, pulling ears; 9JUN 1050AM pain inc in lying position, no rash; med care strongly recommended; 11JUn TC f/u to ER on 10JUN BOM, ? lung congestion; Ceclor, advil cough syrup-t105 R;
Inject site developed large abscess 3x5cm which required incision & drainage on 11MAR91;
Patient complained of shortness of breath/muscle aches/chills approximately 3-4 hours after vaccine and lasting approximately 4 hours - pt. did not go to hospital or doctor - was fine the next day - no pain/soreness at injection site. No reaction to vaccine at injection site.
Swollen lymph node in left armpit; Hives lasting more than 5 days; irregular menstrual onset; blood sugar instability